Calvo-Vázquez I, Sánchez-Luna O, Yáñez-Sosa AL

Language: Spanish
References: 12
Page: 41-49
PDF size: 694.32 Kb.

ABSTRACT

Background: Diabetes mellitus type 2 is a chronic-degenerative disease, which is characterized by chronic hyperglycemia, due to failure to produce insulin or failure of action of insulin. This constant microvascular damage provokes a decreased kidney function catalogued as a chronic kidney disease (CKD): the continuous presence of a kidney damage during at least three moths. Within the first 10 years of diagnosis, 5 to 10% of the patients with type 2 diabetes may develop CKD, which may result in an early nephropathy with microalbuminuria, and with macroproteinuria 15 years later.
Objective: To identify the prevalence of the chronic kidney disease without diagnosis in patients with a 5-year diagnosis of diabetes mellitus type 2.
Material and method: A cross-sectional, descriptive, observational, retrospective study was conducted, which included adult patients that were 50 years and older, and had 5-year diabetes mellitus type 2 diagnosis, without complications mentioned in the UMF 09 San Pedro de los Pinos, IMSS, Mexico City.
Results: This study consisted of 218 patients, 53% of whom were female. It was observed that 65.5% of the population in the study was classified as having stage I and II KDOQI, and 34.41% was detected to have more advanced stages: 28.9% was in stage III, 5% in stage IV and only 0.4% in stage V.
Conclusions: We found a late recognition of this type of complications of a chronic-degenerative pathology that is very frequent in our country; 34.4% of the patients were in an advanced stage for which they need a prompt treatment, this shows the importance of preemptive actions and an early diagnosis in order to be able to offer an improved quality of life to our patients.

REFERENCES

1. Secretaría de Salud de México. Proyecto de modificación a la Norma Oficial Mexicana NOM-015-SSA2-1994 para la prevención, tratamiento y control de la diabetes. Disponible en http://www.salud.gob.mx/unidades/cdi/nom/ m015ssa24.html

2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.

3. Tierney LM, McPhee SJ, Papadakis MA. Current Medical Diagnosis & Treatment. International edition. Nueva York: Lange Medical Books/McGraw-Hill, 2012;1203-1215.

4. Eknoyan G, Lameire N, Eckardt KU, Kasiske BL, et al. KDIGO 2012, Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 2013;3.

5. Cirillo M, Laurenzi M, Mancini M, Zanchetti A, De Santo NG. Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension 2006;47:56-61.

6. Fierro JA, Zavala C. ABC de la nefropatía diabética: una guía práctica para el médico general. Rev Med Clin Condes 2010;21:579-583.

7. Martín de Francisco AL, Aguilera L, Fuster V. Enfermedad cardiovascular, enfermedad renal y otras enfermedades crónicas. Es necesaria una intervención más temprana en la enfermedad renal crónica. Nefrología 2009;29:6-9.

8. Sánchez Becerra D, Cuéllar Mata P. Prevalencia de daño renal en pacientes diabéticos y/o hipertensos mediante prueba tamiz (RAC) en una clínica de Guanajuato. Rev Latinoam Patol Clin 2012;59:28-34.

9. Eelg-You P, Think-You K. The original sin of Cockcroft-Gault formula. Nephrol Dial Transplant 2010;25:1347-1350.

10. Soto Domínguez FE, Pozos Pérez ME. Detección oportuna de insuficiencia renal oculta en pacientes adultos en atención primaria a la salud. Rev Med UV 2009;26-30.

11. Rodríguez Constantin A, Rodríguez Beyris RP. Insuficiencia renal crónica en pacientes con diabetes mellitus de tipo 2 en un área de salud. MEDISAN 2009;13.

12. Laclé-Murray A. Prevalencia de nefropatía diabética y sus factores de riesgo. Instituto de Investigación en Salud. Acta Méd Costarric 2009;51.